Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
作者信息
Bilchik Anton J, Hecht J Randolph
出版信息
J Clin Oncol. 2008 Apr 10;26(11):1786-8. doi: 10.1200/JCO.2007.15.6380.
PMID:18398144
Abstract
摘要
相似文献
1
Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
J Clin Oncol. 2008 Apr 10;26(11):1786-8. doi: 10.1200/JCO.2007.15.6380.
2
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Ann Surg Oncol. 2007 Feb;14(2):759-65. doi: 10.1245/s10434-006-9074-0. Epub 2006 Nov 11.
3
In search of the black sheep: is it bevacizumab or extended chemotherapy?
Ann Surg Oncol. 2009 Jun;16(6):1463-4. doi: 10.1245/s10434-009-0450-4. Epub 2009 Apr 9.
4
Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a case-matched study in 82 patients.
Ann Surg. 2012 Nov;256(5):755-61; discussion 761-2. doi: 10.1097/SLA.0b013e31827381ca.
5
Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
Ann Surg Oncol. 2009 Jun;16(6):1553-9. doi: 10.1245/s10434-009-0447-z. Epub 2009 Apr 11.
6
Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.
J Clin Oncol. 2005 Aug 1;23(22):4853-5. doi: 10.1200/JCO.2005.23.754.
7
[The safety of perioperative bevacizumab use].
J Chir (Paris). 2010 Jan;147 Suppl 1:S12-7. doi: 10.1016/S0021-7697(10)70003-X.
8
Bevacizumab and postoperative complications after hepatic surgery for colorectal metastases.
J Clin Oncol. 2009 Apr 10;27(11):1917; author reply 1918. doi: 10.1200/JCO.2008.21.1755. Epub 2009 Mar 2.
9
[Roles of hepatectomy for colorectal liver metastases with necrotic foci caused by prior anti-cancer therapies].
Gan To Kagaku Ryoho. 2010 Nov;37(12):2569-72.
10
Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
Clin Colorectal Cancer. 2006 Sep;6(3):202-7. doi: 10.3816/CCC.2006.n.036.
引用本文的文献
1
Conversion therapy of stage IVb unresectable gallbladder carcinoma.
Hepatobiliary Surg Nutr. 2022 Apr;11(2):335-337. doi: 10.21037/hbsn-22-78.
2
Current treatment options for patients with initially unresectable isolated colorectal liver metastases.
World J Clin Oncol. 2016 Feb 10;7(1):9-14. doi: 10.5306/wjco.v7.i1.9.
3
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer.
Nat Rev Clin Oncol. 2009 Apr;6(4):207-18. doi: 10.1038/nrclinonc.2009.16.
Zotero 插件